SILODOSIN (Page 5 of 5)

16 HOW SUPPLIED/STORAGE AND HANDLING

White, opaque, hard gelatin 8 mg capsules. Cap is imprinted with “S” in black ink. Body is imprinted with “8 mg”. 8 mg capsules are supplied as:

  • 30 capsules (NDC 72205-010-30)
  • 90 capsules (NDC 72205-010-90)

Bottles of 30 and 90 capsules are supplied with child-resistant closures.
White, opaque, hard gelatin 4 mg capsules. Cap is imprinted with “S” in black ink. Body is imprinted with “4mg”. 4 mg capsules are supplied as:

  • 30 capsules (NDC 72205-009-30)

Bottles of 30 capsules are supplied with child-resistant closures.
Storage
Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F). [See USP controlled room temperature.] Protect from light and moisture.
Keep out of reach of children.

17 PATIENT COUNSELING INFORMATION

Advise patients to take silodosin once daily with a meal [see Dosage and Administration (2.1)].
Advise patients about the possible occurrence of symptoms related to postural hypotension (such as dizziness), and should be cautioned about driving, operating machinery, or performing hazardous tasks until they know how silodosin will affect them. This is especially important for those with low blood pressure or who are taking antihypertensive medications [see Warnings and Precautions (5.1)].
Counsel patients on that the most common side effect seen with silodosin is an orgasm with reduced or no semen. This side effect does not pose a safety concern and is reversible with discontinuation of the product [see Adverse Reactions (6.1)].
Counsel patients to tell their ophthalmologist about the use of silodosin before cataract surgery or other procedures involving the eyes, even if the patient is no longer taking silodosin [see Warnings and Precautions (5.7)].

Rx only

Manufactured by:

MSN Laboratories Private Limited
Telangana – 509 228,
INDIA
Distributed by:
Novadoz Pharmaceuticals LLC
Piscataway, NJ 08854-3714
Issued on: January 2021

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

4mg-container-label-30s-count

4mg-30s-cntr
(click image for full-size original)

8mg-container-label-30s-count

8mg-30s-cntr
(click image for full-size original)

8mg-container-label-90s-count

8mg-90s-cntr
(click image for full-size original)
SILODOSIN silodosin capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72205-009
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SILODOSIN (SILODOSIN) SILODOSIN 4 mg
Inactive Ingredients
Ingredient Name Strength
MAGNESIUM STEARATE
MANNITOL
POLYSORBATE 80
TITANIUM DIOXIDE
SHELLAC
PROPYLENE GLYCOL
POTASSIUM HYDROXIDE
GELATIN
FERROSOFERRIC OXIDE
STARCH, CORN
MAGNESIUM ALUMINOMETASILICATE TYPE IA
Product Characteristics
Color WHITE Score no score
Shape CAPSULE Size 15mm
Flavor Imprint Code S;4mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72205-009-30 30 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA210687 12/03/2018
SILODOSIN silodosin capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72205-010
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SILODOSIN (SILODOSIN) SILODOSIN 8 mg
Inactive Ingredients
Ingredient Name Strength
MAGNESIUM STEARATE
MANNITOL
POLYSORBATE 80
TITANIUM DIOXIDE
SHELLAC
PROPYLENE GLYCOL
POTASSIUM HYDROXIDE
GELATIN
FERROSOFERRIC OXIDE
STARCH, CORN
MAGNESIUM ALUMINOMETASILICATE TYPE IA
Product Characteristics
Color WHITE Score no score
Shape CAPSULE Size 19mm
Flavor Imprint Code S;8mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72205-010-30 30 CAPSULE in 1 BOTTLE None
2 NDC:72205-010-90 90 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA210687 12/03/2018
Labeler — Novadoz Pharmaceuticals LLC (081109687)
Registrant — Novadoz Pharmaceuticals LLC (081109687)
Establishment
Name Address ID/FEI Operations
MSN LABORATORIES PRIVATE LIMITED 650786952 ANALYSIS (72205-009), ANALYSIS (72205-010), MANUFACTURE (72205-009), MANUFACTURE (72205-010)

Revised: 07/2021 Novadoz Pharmaceuticals LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.